You are here

Clinical Pathology

Clinical Pathology


eISSN: 2632010X | ISSN: 2632010X | Current volume: 16 | Current issue: 1 Frequency: Yearly

Clinical Pathology was published previously as Clinical Medicine Insights: Pathology.

Journal Highlights

  • Indexed in PubMed Central (PMC), Scopus, ESCI, ProQuest, EBSCO, and the DOAJ
  • Published since 2008
  • Publication is subject to payment of an article processing charge (APC)

Clinical Pathology is an open access, peer reviewed international journal that focuses on and solicits manuscripts that address all aspects of pathology, translational research, basic research focusing on biochemical and molecular mechanisms involved in pathogenesis, the genetic basis of pathology, immune-mediated pathogenesis, pharmacogenomics, bioinformatics, precision medicine, novel therapies, infection control and medical microbiology. Please see the Aims and Scope tab for further information.

This journal is a member of the Committee on Publication Ethics (COPE).


Submission Information

Submit your manuscript here.
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.


Open access article processing charge (APC) information

Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons license.

The APC for this journal is currently $2800 USD. The APC for Brief Reports and Case Reports is $750 USD.

The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.


Contact

Please direct any queries to Samantha Crown at samantha.crown@sagepub.com.

 

Clinical Pathology was published previously as Clinical Medicine Insights: Pathology.

Clinical Pathology is an international, peer-reviewed, open access journal that focuses on all aspects of clinical pathology, including pathogenesis, diagnostics, the genetic basis of pathology, translational research, infection control, and medical microbiology. Manuscripts regarding precision medicine and novel therapies are of particular interest.

Special Section on Digital pathology

This special section on digital pathology focuses on imaging technologies to digitize traditional pathological slides, revolutionizing diagnostic and theragnostic processes. By integrating computational analysis and machine learning, digital pathology enhances our ability to extract detailed insights from tissue samples. This transformation also enables telepathology, fostering collaboration and, in some cases, improving diagnostic accuracy. This digitization also enables the collection of supplementary data, such as metadata, beyond traditional pathological staining.

We welcome submissions that explore a broad range of topics within digital pathology, including but not limited to:

  • Research methods and commentary in computational pathology, whether applying existing techniques to solve newly encountered issues or applying new techniques to solve existing issues
  • Innovative technologies and methods for digitizing pathology slides
  • Machine learning and artificial intelligence applications in the analysis of digitized pathological data in clinical diagnosis
  • Comparative studies on the efficacy of digital versus traditional pathology
  • Telepathology applications and their impact on healthcare resources and service delivery
  • Advanced data analytics and visualization techniques in pathology

Special Section on Molecular Pathology

This special section seeks to highlight the latest research, innovations, and practical applications relating to histopathology and cytopathology, predictive pathology, and molecular cytopathology. We welcome submissions that explore a broad range of topics within molecular pathology, including but not limited to:

  • Innovative research methods and commentary in general and precision medicine practice, whether applying existing techniques to solve newly encountered issues or applying new techniques to solve existing issues
  • Integration of molecular techniques in routine histopathology and cytopathology
  • Novel biomarkers for disease diagnosis, prognosis, and therapeutic targets
  • Advances in genomic, proteomic, and metabolomic reporting of diseases
  • Development and validation of new molecular innovations and technologies
  • Challenges and solutions in the implementation of molecular pathology in clinical practice

Special Section on Ethics and Policy

This sections seeks to foster a comprehensive discussion on the critical intersections of ethics, law, society, and innovation in pathology. We invite submissions focusing on the ethical, legal, and social implications of novel and innovative approaches to pathology research and practice. Of particular interest are studies exploring the broader impact of advancements in pathology, particularly in relation to public health priorities and the integration of pathology data into real-world evidence for policy-making by regulators and payers.

We welcome submissions that explore a broad range of topics, including but not limited to:

  • Commentary/perspective on ethical, legal, social implications (ELSI) for novel/innovative approaches to pathology research and practice
  • Public health priorities in clinical, molecular, and/or digital pathology
  • Contributing pathology data generated/collected in routine clinical settings to the totality of real-world evidence needed to inform policymakers and/or practitioners (e.g., regulators, payers, health technology assessment, health systems, etc.)
  • Ethics training and professionalism education, especially since direct patient interaction is limited in the practice of pathology
  • Ethics in laboratory medicine practice and/or forensic pathology
  • Ethics or ELSI case studies in clinical, molecular, and/or digital pathology

The journal welcomes submissions on the following topics:

  • Pathogenesis
  • Hematopathology
  • Transfusion medicine
  • Immunopathology
  • Medical microbiology
  • Molecular pathology
  • Biochemical pathology
  • Molecular diagnostics
  • Histopathology
  • Cytogenetics
  • Infection control
  • Virology
  • Parasitology
  • Microbial virulence
  • Pharmacogenomics
  • Translational Research
  • Precision medicine
  • Novel therapies
  • Bioinformatics

Criteria for Publication Statement

Our goal is to publish sound science. This means we look for research that adheres to ethical standards, uses robust methodologies that are transparent and reproducible, and uses appropriate statistical analyses to ensure clear, credible, and trustworthy results. We care more about the quality and reliability of the contribution an article makes than we do the size of that contribution. Clinical Pathology evaluates manuscripts based on how the research was conducted and reported.     

Editor-in-Chief
Rachele Hendricks-Sturrup, DHSc, MSc, MA Research Director, Real World Evidence, Duke-Robert J. Margolis, MD, Center for Health Policy
Editorial Board
Richard J. Ablin University of Arizona College of Medicine, USA
Michael Autieri Temple University School of Medicine, USA
Massimiliano Marco Corsi Romanelli, MD PhD FRCP Faculty of Medicine, University of Milan, Italy
Dr. Mohamed A. Elmonem Faculty of Medicine, Cairo University, Egypt
Nour S. Erekat, PhD Jordan University of Science and Technology, Jordan
Xiangqian Guo School of Medicine, Henan University, China
Dr. Reham Zakaria Hamza Zagazig University, Egypt
Mohammed Hosny Hassan, MD Faculty of Medicine, South Valley University, Egypt
David G. Kaufman University of North Carolina at Chapel Hill, USA
Peter J. Kragel, MD East Carolina University Brody School of Medicine, USA
Alexander Y. Nikitin Cornell University, Ithaca, New York, USA
Gene P. Siegal University of Alabama at Birmingham, USA
Finosh G. Thankam, PhD Western University of Health Sciences, USA
Hong Wang Temple University School of Medicine, USA
Eugenia Yiannakopoulou, MD, MSc, PhD University of West Attica, Athens, Greece
Editorial Review Board
Soniya Abraham, MD University of Texas Health Science Center San Antonio, USA
Adriana Amfim, PhD MDV Faculty of Veterinary Medicine, Spiru Haret University, Bucharest, Romania
Dr. Furkan Bilek, PhD Mugla Sitki Koçman University, Fethiye Faculty of Health Sciences, 48300 Fethiye, Mugla/TÜRKIYE
Shatavisha Dasgupta, MD, PhD Broad Institute of MIT and Harvard, Cambridge, USA
Dr. Eslam S. Elsherbiny, PhD Damietta University, Egypt
Dr Nivea T. Francis, BDS, MDS (Prosthodontics) KUHS University, India
Ying Liu, PhD Children's Hospital of Soochow University, China
Yi Mou Mphil & MSc The Eighth Municipal Hospital for the People
Alex Mremi, MD Department of Pathology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania
Muhammed Mubarak, MBBS, DCP (London), MCPS, FCPS Professor, Section Head, Histopathology Department, and Head of Clinical Laboratory, SIUT, Karachi, Pakistan
Satish Panchal, BVSc (DVM), MVSc, DIBTP, ERT(UK), DABT, Fellow IATP LabCorp Early Development Laboratories Ltd
Dr Niveditha S Prasad, MDS Kmct dental college, India
Luca Roncati University Hospital of Modena, University of Modena and Reggio Emilia, Italy
Jyoti Prakash Sahoo, MBBS, MD, CCEBDM Kalinga Institute of Medical Sciences, India
Mahsa Samangooei, Phd Shahid Sadoughi University of Medical Science, Iran
Dr. Ravi Kumar Sharma, Ph.D. (PGIMER) Department of Biotechnology, Chandigarh University, Mohali, Punjab, India.
Shailja Singh, MSc, UGC-NET Qualified NIMS University Rajasthan, Jaipur
Brittany Teeter, M.S CLS MLS(ASCP)CM UT-Health San Antonio, USA
Xiaobo Wen, MD, PhD Student Qingdao Cancer Institute, Qiaodao University
  • Clarivate Analytics: Emerging Sources Citation Index (ESCI)
  • Directory of Open Access Journals (DOAJ)
  • EBSCO
  • ProQuest
  • PubMed Central (PMC)
  • Scopus